U.S. ELASTOMERIC INFUSION PUMPS MARKET ANALYSIS

U.S. Elastomeric Infusion Pumps Market, by Product Type (Variable Rate Elastomeric Pumps and Continuous Rate Elastomeric Pumps), By Indication ( Oncology, Post-operative Care, General Medicine, and Others), By End User ( Ambulatory Surgical Centers, Clinics, Home Care Settings ( Oncology, Post-operative Care, General Medicine & Others ), Hospitals and Others) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Jun 2021
Code : CMI4452
Pages :106
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

Moreover, stringent regulations regarding the use of plastics in elastomeric infusion pumps is expected to hamper the market growth. For instance, the European Commission and the U.S. FDA published safety assessments of medical devices containing Di (2-ethylhexyl) phthalate (DEHP) and plasticized polyvinylchloride (PVC) in certain parts of elastomeric infusion pumps.

Therefore, manufacturers need to focus on proper safety labelling of products to avoid severe side effects, especially in neonatal patient population.

Furthermore, the cost of elastomeric infusion pumps keep fluctuating depending on the type of the pump.

For instance, the cost of pumps administering antibiotics is significantly low, whereas the cost of pumps administering pain management drugs is relatively high and ranges between US$ 160 and US$ 450. Such factors is expected to hinder growth of the U.S. elastomeric infusion pumps market over the forecast period.